PLAY PODCASTS
OncLive® On Air

OncLive® On Air

OncLive® On Air · Audioboom

581 episodesEN

Show overview

OncLive® On Air has been publishing since 2022, and across the 4 years since has built a catalogue of 581 episodes. That works out to roughly 170 hours of audio in total. Releases follow a several-times-a-week cadence, with the show now in its 16th season.

Episodes typically run ten to twenty minutes — most land between 11 min and 22 min — though episode length varies meaningfully from one episode to the next. None of the episodes are flagged explicit by the publisher. It is catalogued as a EN-language Health & Fitness show.

The show is actively publishing — the most recent episode landed yesterday, with 160 episodes already out so far this year. The busiest year was 2025, with 172 episodes published. Published by Audioboom.

Episodes
581
Running
2022–2026 · 4y
Median length
15 min
Cadence
Several per week

From the publisher

In OncLive® On Air, you can expect to hear interviews with academic oncologists on the thought-provoking oncology presentations they give at the OncLive® State of the Science Summits. The topics in oncology vary, from systemic therapies, surgery, radiation therapy, to emerging therapeutic approaches in a particular type of cancer. This includes lung cancer, breast cancer, gastrointestinal cancers, hematologic malignancies, gynecologic cancers, genitourinary cancers, and more.

Latest Episodes

View all 581 episodes

S18 Ep29: 𝘔𝘌𝘛 Alterations in NSCLC: Applying Diagnostic Advances and Targeted Therapies in a New Era of Treatment

Aug 24, 202629 min

S18 Ep28: Pancreatic Cancer Treatment Advances Call for a Renewed Focus on the Role of Liposomal Irinotecan: With Jennifer B. Valerin, MD, PhD

Aug 20, 202617 min

S17 Ep75: Key Considerations for Health Equity and Patient-Centered Care in TNBC

Aug 17, 202625 min

S17 Ep77: FDA Approval Insights: Gedatolisib Plus Fulvestrant ± Palbociclib for HR+, HER2-Negative, PIK3CA Wild-Type Advanced Breast Cancer: With Adam M. Brufsky, MD, PhD

Aug 14, 202610 min

S17 Ep76: Greater Flexibility and Improved QOL Represent Key Potential Benefits With Liquid TKI Formulations: With Jonathan Trent, MD, PhD

Aug 7, 202615 min

S17 Ep74: Precision Oncology, Bispecific Antibodies, and Next-Generation Targeted Therapies Are Reshaping NSCLC Care: With Chandler Park, MD; Stephen V. Liu, MD

Aug 4, 202623 min

S17 Ep73: From Trials to the Clinic: Incorporating New Advances in Metastatic TNBC

Aug 3, 202625 min

S17 Ep72: FDA Approval Insights: Subcutaneous Isatuximab Via an On-Body Delivery System Represents a “Game-Changer” in Multiple Myeloma: With Douglas W. Sborov, MD, MS

Jul 31, 20267 min

S17 Ep69: Positioning PD-L1/VEGF Bispecifics in First-Line Non–Small Cell Lung Cancer: With Solange Peters, MD, PhD

Jul 31, 202610 min

S17 Ep71: Biomarker-Driven Shifts Signal the Next Generation of mCRC Therapies: With Tanios S. Bekaii-Saab, MD

Jul 30, 202624 min

S17 Ep70: Navigating Fixed-Durations Regimens in CLL and Improving Outcomes for High-Risk Patients: With John N. Allan, MD

Jul 30, 202617 min

S17 Ep68: Sequencing Systemic and Liver-Directed Therapy in HLA-A*02:01–Negative Metastatic Uveal Melanoma: With Marlana M. Orloff, MD

Jul 29, 202618 min

S17 Ep67: Experts Bridge Oncology and Neurology to Catch LEMS Earlier in SCLC: With Misty D. Shields, MD, PhD; Triparna Sen, MD, PhD, MS; and Ditte Primdahl, MD

Jul 28, 202648 min

S17 Ep66: FDA Approval Insights: Orca-T Raises the Bar for Allogeneic Transplants in Hematologic Malignancies: With Everett Meyer, MD, PhD

Jul 28, 20266 min

S17 Ep65: ASCO 2026 ADC Data Clarify Some Strategies and Raise Further Questions for Breast Cancer Care: With Paolo Tarantino, MD, PhD

Jul 28, 202612 min

S17 Ep64: FDA Approval Insights: First-Line Sacituzumab Govitecan Plus Pembrolizumab for PD-L1+ TNBC: With Sara M. Tolaney, MD, MPH

Jul 28, 20265 min

S17 Ep63: FDA Approval Insights: Orally Disintegrating Nilotinib Tablets for CML: With Jorge E. Cortes, MD; and Elias Jabbour, MD

Jul 28, 20269 min

S17 Ep61: Treat Early and Aggressively: Optimizing Small Cell Lung Cancer Management Across the Community Setting: With Joshua Sabari, MD

Jul 24, 202617 min

S17 Ep62: Hot Seat: Which Agent, and When? Integrating Next-Generation Endocrine Strategies Into HR+/HER2– Breast Cancer Management

Jul 24, 202631 min

S17 Ep60: Cases and Conversations: Adopting New Treatment Strategies in Polycythemia Vera and Essential Thrombocythemia

Jul 23, 202629 min